- Question from Arnette: What is the current opinion on taking Zometa twice a year to prevent a recurrence and increase bone density? Is it harmful?
- Answers - Eric Winer, M.D. There was a large study reported at San Antonio using the drug Zometa, albeit more frequently than twice a year, to prevent bone metastasis. That study, unlike previous studies, did not suggest that Zometa helps prevent bone metastasis or other metastasis. At the moment, other than in very specific situations, most medical oncologists would not recommend the use of Zometa to prevent metastatic disease. It is a drug that can be used to prevent bone loss related to osteoporosis, but that would only involve a once-a-year dose.
The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
Editor's Note: This conference took place in December 2010.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.